BANGKOK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the closing of its previously announced public offering made on a reasonable best efforts basis with gross proceeds to the Company of approximately $1.25 million, before d
Chemicals and pharmaceuticals sit behind an extraordinary range of products, industries and technologies. The sector is now evolving through advances in process engineering, specialty chemistry, pharmaceutical manufacturing, biotechnology, materials science and digital technology. This edition examines the changing landscape across chemicals and pharma, exploring how scientific innovation and modern manufacturing are reshaping the development of molecules, medicines and materials while creating new possibilities across the industries that depend upon them.
Chemistry rarely operates in isolation. Its influence extends from medicines and materials to agriculture, electronics, mobility and everyday consumer products. This edition opens a wider conversation about the transformation taking place across chemicals and pharmaceuticals, examining how science, engineering and manufacturing are converging and why the industry's next phase will increasingly depend on innovation across traditional boundaries.